Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.

NCT00189956 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Smallpox

Interventions

BIOLOGICAL: IMVAMUNE (MVA-BN)

Sponsor

Bavarian Nordic

Collaborators

[object Object]